| 2015 |
COMMD9, together with its binding partner COMMD5, is specifically required within the CCC (COMMD-CCDC22-CCDC93) complex for endosomal recycling of Notch receptors to the cell surface; disruption of COMMD9 causes intracellular accumulation of Notch2 and reduced Notch signaling, while Commd9 deletion in mice causes embryonic lethality with cardiovascular defects bearing hallmarks of Notch deficiency. |
siRNA knockdown, co-immunoprecipitation, fluorescence microscopy of Notch2 trafficking, Commd9 conditional knockout mouse with phenotypic analysis |
The Journal of cell biology |
High |
26553930
|
| 2016 |
The CCC complex (containing COMMD9) and the WASH complex cooperate to mediate endosomal sorting of LDLR back to the cell surface; hepatic COMMD9 deficiency in mice leads to LDLR mislocalization, increased lysosomal degradation of LDLR, impaired LDL uptake, and elevated plasma LDL cholesterol levels. |
Liver-specific Commd9 knockout mice, plasma cholesterol measurements, LDLR localization by microscopy, LDL uptake assays |
Nature communications |
High |
26965651
|
| 2016 |
COMMD9 interacts with TFDP1 (DP1) through its COMM domain; the DNA-binding domain of TFDP1 is required for this interaction; COMMD9 promotes TFDP1/E2F1 transcriptional activity, and COMMD9 knockdown attenuates TFDP1/E2F1 activation and enhances p53 signaling in NSCLC cells, arresting the cell cycle at G1/S. |
Co-immunoprecipitation, domain-deletion mapping, siRNA knockdown with luciferase reporter assays, cell cycle analysis, and autophagy assays |
Cellular signalling |
Medium |
27871936
|
| 2018 |
COMMD9 (like COMMD1 and COMMD6) is required for the stability of the entire COMMD protein family and the core CCC complex (CCDC22, CCDC93, C16orf62); hepatic Commd9 knockout causes massive reduction in all 10 COMMD protein levels, destabilization of the CCC core, reduced cell-surface levels of LDLR and LRP1, hypercholesterolemia, and accelerated atherosclerosis. |
Liver-specific Commd9 knockout mice, quantitative targeted proteomics, Western blotting, cell surface receptor quantification, plasma lipid measurements, atherosclerosis assessment in ApoE3*Leiden mice |
Circulation research |
High |
29545368
|
| 2013 |
COMMD9 interacts with the epithelial sodium channel (ENaC) and reduces amiloride-sensitive current by decreasing ENaC cell surface expression; this effect is retained when COMMD1 is knocked down, indicating a COMMD1-independent mechanism. |
Co-immunoprecipitation, electrophysiological current measurement (Ussing chamber), cell surface biotinylation, COMMD1 siRNA knockdown, immunofluorescence colocalization in renal collecting duct cells |
American journal of physiology. Renal physiology |
Medium |
23637203
|
| 2021 |
Hepatic Commd9 deficiency (like Commd1 and Commd6 deficiency) causes destabilization of the entire CCC complex and leads to hepatic copper accumulation under high-copper diets, consistent with impaired ATP7B endosomal recycling; by contrast, enterocyte-specific Commd9 deficiency does not significantly alter ATP7A regulation or intestinal copper absorption. |
Hepatocyte-specific and enterocyte-specific Commd9 knockout mice, tissue copper level measurements, Western blotting for CCC complex components, ATP7B localization |
Disease models & mechanisms |
Medium |
33262129
|
| 2025 |
Pathogenic mutations in COMMD9 (identified in Ritscher-Schinzel syndrome patients) disrupt Commander complex assembly; interactome analysis showed reduced binding of mutant COMMD9 to Commander subunits, and cell surface proteomics showed tissue-specific reduction in presentation of integral membrane proteins containing ΦxNPxY/F or ΦxNxxY/F sorting motifs recognized by SNX17, establishing COMMD9 as essential for SNX17-dependent endosomal recycling of multiple cargo proteins critical for kidney, bone, and brain development. |
Patient genetic analysis, interactome/co-immunoprecipitation assays, cell surface proteomics, mouse models of RSS with proteinuria, skeletal malformation, and neurological phenotypes |
Science translational medicine |
High |
40601774
|
| 2022 |
Silencing of COMMD9 abrogates ETV6 repressive transcriptional activity in pre-B acute lymphoblastic leukemia cells, identifying COMMD9 as a modulator of ETV6 function. |
Genome-wide shRNA screen in pre-B ALL cells followed by validation of ETV6 target gene expression upon COMMD9 knockdown |
iScience |
Low |
35198911
|